The differential prognostic outcomes based on PDE2A expression levels may be attributed to multiple factors, including specific tumor types, tumor heterogeneity, epigenetic modifications, complex gene-gene interactions, tumor microenvironment, and other factors (29). This evidence concerns the gene PDE2A and neoplasm.